Emerging Markets Earnings Round Up: Sanofi And BMS (Part 6)
This article was originally published in PharmAsia News
Executive Summary
Sanofi sees China sales dip slightly in Q3, but expects sales to rebound in the next few quarters as it sets its sights on other emerging markets such as Vietnam and Africa. Bristol Myers Squibb piggybacks on brands like Baraclude and Orencia to grow deeper in China and greater Asia.